Covered recipient · General Payments record
HAO HAO TANG
Allopathic & Osteopathic Physicians Ophthalmology Retina Specialist
General Payments · PY2018–2024
$110,109.13
- Reported across 74 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $15,345.00 | 3 |
| Travel and Lodging | $1,352.63 | 8 |
| Food and Beverage | $1,283.83 | 21 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $10,275.74 | 15 |
| Genentech USA, Inc. | $7,041.55 | 6 |
| Genentech, Inc. | $282.46 | 4 |
| Regeneron Healthcare Solutions, Inc. | $150.39 | 2 |
| Astellas Pharma US Inc | $143.85 | 2 |
| Apellis Pharmaceuticals, Inc. | $60.88 | 2 |
| Astellas Pharma Global Development | $26.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (32)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2018201920222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.64 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106199812 | CMS |
| ABBVIE INC. | $625.43 | 10/04/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1106199814 | CMS |
| ABBVIE INC. | $208.12 | 10/04/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1106199816 | CMS |
| ABBVIE INC. | $66.76 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106199818 | CMS |
| ABBVIE INC. | $123.26 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106199820 | CMS |
| ABBVIE INC. | $41.11 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106199822 | CMS |
| ABBVIE INC. | $24.59 | 10/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106199824 | CMS |
| ABBVIE INC. | $59.06 | 10/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106199826 | CMS |
| ABBVIE INC. | $15.62 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106199828 | CMS |
| ABBVIE INC. | $19.38 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106199830 | CMS |
| ABBVIE INC. | $9.92 | 10/23/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1106199832 | CMS |
| ABBVIE INC. | $21.85 | 10/23/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1106199834 | CMS |
| ABBVIE INC. | $42.00 | 10/23/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1106199836 | CMS |
| ABBVIE INC. | $3,600.00 | 11/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106199838 | CMS |
| ABBVIE INC. | $5,400.00 | 11/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106199840 | CMS |
| Apellis Pharmaceuticals, Inc. | $26.71 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154021561 | CMS |
| Apellis Pharmaceuticals, Inc. | $34.17 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154021563 | CMS |
| Astellas Pharma Global Development | $26.59 | 11/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132966347 | CMS |
| Astellas Pharma US Inc | $98.68 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139450260 | CMS |
| Astellas Pharma US Inc | $45.17 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139351939 | CMS |
| Genentech USA, Inc. | $22.00 | 04/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1133018204 | CMS |
| Genentech USA, Inc. | $17.24 | 04/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133018209 | CMS |
| Genentech USA, Inc. | $234.00 | 04/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133018213 | CMS |
| Genentech USA, Inc. | $6,345.00 | 04/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133018217 | CMS |
| Genentech USA, Inc. | $187.84 | 04/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1133018221 | CMS |
| Genentech USA, Inc. | $235.47 | 04/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1133018225 | CMS |
| Genentech, Inc. | $34.50 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133018229 | CMS |
| Genentech, Inc. | $59.55 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133018237 | CMS |
| Genentech, Inc. | $141.18 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133018200 | CMS |
| Genentech, Inc. | $47.23 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133018233 | CMS |
| Regeneron Healthcare Solutions, Inc. | $114.15 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114211203 | CMS |
| Regeneron Healthcare Solutions, Inc. | $36.24 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114211209 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.